Chiara obtained a double PhD degree in pharmaceutical sciences (UCLouvain - University of Angers, Erasmus Mundus NanoFar program) under the joint supervision of Prof. Preat, Prof. Lagarce, Dr. Danhier and Dr. Bastiat. Her PhD project led to several publications in high impact factor journals & proceedings in (inter)national conferences and set the basis for four projects
that are currently on going. Her work has been recognized with 5 international prizes, including the Controlled Release Society Italy Chapter 2018 PhD Award. Since June 2018, Chiara is a postdoctoral fellow at the Gliomagenesis and MicroEnvironment research group of the Aix Marseille University. Chiara’s research focus is the development of drug-loaded nano-sized delivery systems as potential solutions for unmet medical needs. Coming from a family of scientists, artists, cooking- and travelling-lovers, Chiara grew up with the idea that new is good, international is fun and passion is the key. This allowed her to develop a global vision of science, create her own network of drug delivery and cancer research experts and become a T-shaped researcher able to develop academic research in a bench to bedside perspective. Her research is centered on the treatment of brain tumor glioblastoma via the local or systemic delivery of nanomedicines. In addition to her passion for research, Chiara has a strong interest in teaching, student’s supervision and she is very keen in pursuing an academic career. Chiara joined the Controlled Release Society to promote the work of her lab into the drug delivery community and to develop collaborations that might lead to exciting and patient- oriented projects to increase the translational impact of her work. From a personal perspective, joining the Early Career Scientist Committee of the CRS BeNeLux & France Local Chapter as Mentorship Program Coordinator will allow Chiara to create her own network, learn about mentorship strategies, implement her managing and organizing skills and help young scientists to find their career pathway.